Virax Biolabs VRAX Income Statement (2021-2026)

NASDAQ VRAX
$3.45 +0.27 (+8.49%)
At close: Aug 20, 2026 · 4:00 PM EDT
Income Statement Mar2021 Mar2022 Mar2023 Sep2023 Mar2024 Sep2024 Mar2025 Sep2025 Mar2026
Net income details
Income towards Parent Company (Quarter) 5.70M7.58M
Net Income towards Common Stockholders (Quarter) 5.70M7.58M
Additional items
EPS (Basic) (Quarter) 38.1719.06
EPS (Diluted) (Quarter) 38.1719.06
Shares Outstanding (Quarter) 0.01M0.01M0.04M0.08M0.12M0.15M0.40M
Shares Outstanding (Diluted) (Quarter) 0.01M0.01M0.04M0.08M0.08M0.15M0.40M
Shares Outstanding (Entity) (Quarter) 0.01M0.01M0.04M0.08M0.12M0.17M0.40M
Interest Expenses (Quarter) 0.01M0.01M-0.08M0.00M